Anqian Zhou

Search results

• 2024

  Iptacopan for treating paroxysmal nocturnal haemoglobinuria: A Single Technology Appraisal

  Rodgers, M., Kunst, N., Umemneku-Chikere, C., Zhou, A., Gao, M., Fulbright, H. A., Eastwood, A. J. & Rothery, C., 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Ublituximab for treating relapsing multiple sclerosis: A Cost Comparison Evaluation

  Zhou, A., Uphoff, N., Corbett, M. S., Fulbright, H., Rothery, C. & Simmonds, M. C., 29 Nov 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report
• 2023

  Burosumab for treating X-linked hypophosphataemia in adults: External Assessment Group Report for the National Institute for Health and Care Excellence

  Llewellyn, A., Zhou, A., Phung, H., Njoroge, M. W., Harden, M., Walker, S. M., Simmonds, M. C. & Rothery, C., Nov 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Dupilumab for treating prurigo nodularis: External Assessment Group Report for the National Institute for Health and Care Excellence

  Corbett, M. S., Zhou, A., Anwer, S., Wade, R., Chen, T., Fulbright, H. A., Bojke, L., Eastwood, A. J. & Rothery, C., Aug 2023, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report